About 2 Trademarks found for “IMBARVA”

Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals

Pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of the central nervous system namely central nervous system infections, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's disease, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases namely mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of urological, urogenital and urinary disorders; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of rheumatism; pharmaceutical preparations for the treatment of diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, dermatitis, skin pigmentation diseases, sexually transmitted diseases, immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes, respiratory diseases, and for anti-inflammatories, anti-infectives, hematological preparations, antibacterials, antivirals, antifungals, anti-cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, ophthalmological preparations and hormonal preparations; vaccines for human use; diagnostic preparations for medical diagnostic use.